ImClone Investigational Site — New York, New York

ImClone Investigational Site is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

ImClone Investigational Site has participated in 27 clinical trials.

Therapeutic areas: Hepatocellular Carcinoma, Sarcoma, Soft Tissue, Non Small Cell Lung Cancer.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ImClone Investigational Site?

ImClone Investigational Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ImClone Investigational Site conducted?

ImClone Investigational Site has 27 clinical trials on record. Their work covers Hepatocellular Carcinoma, Sarcoma, Soft Tissue, Non Small Cell Lung Cancer.

Is ImClone Investigational Site accredited by Crixeo Health?

ImClone Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ImClone Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.